Demonstrated hands-on experience developing, executing, and interpreting cell-based assays usingmultiple assay formats and platforms, including functional assays, target engagement assays, kineticassays, plate-based assays, flow cytometry, and high-content imaging. The Company’s platform aims to create candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure.